These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1416 related articles for article (PubMed ID: 17122504)

  • 21. Serrated pathway in colorectal carcinogenesis.
    Yamane L; Scapulatempo-Neto C; Reis RM; Guimarães DP
    World J Gastroenterol; 2014 Mar; 20(10):2634-40. PubMed ID: 24627599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological and molecular features of colorectal serrated neoplasias with different mucosal crypt patterns.
    Yano Y; Konishi K; Yamochi T; Katagiri A; Nozawa H; Suzuki H; Toyota M; Kubota Y; Muramoto T; Kobayashi Y; Tojo M; Konda K; Makino R; Kaneko K; Yoshikawa N; Ota H; Imawari M
    Am J Gastroenterol; 2011 Jul; 106(7):1351-8. PubMed ID: 21427714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women.
    Samadder NJ; Vierkant RA; Tillmans LS; Wang AH; Weisenberger DJ; Laird PW; Lynch CF; Anderson KE; French AJ; Haile RW; Potter JD; Slager SL; Smyrk TC; Thibodeau SN; Cerhan JR; Limburg PJ
    Gastroenterology; 2013 Aug; 145(2):348-56.e1-2. PubMed ID: 23665275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia Pathway.
    Rhee YY; Kim KJ; Kang GH
    Gut Liver; 2017 Jan; 11(1):38-46. PubMed ID: 27885175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature.
    Young J; Jass JR
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1778-84. PubMed ID: 17035382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CpG island methylation is frequently present in tubulovillous and villous adenomas and correlates with size, site, and villous component.
    Kakar S; Deng G; Cun L; Sahai V; Kim YS
    Hum Pathol; 2008 Jan; 39(1):30-6. PubMed ID: 17950780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Immunophenotypes and gene mutations in colorectal precancerous lesions and adenocarcinoma].
    Huang WT; Qiu T; Ling Y; Shi SS; Guo L; Zheng B; Lü N; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2013 Oct; 42(10):655-9. PubMed ID: 24433726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
    Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A
    J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of histologically distinct conventional adenomas that arise predominately in patients with sessile serrated adenomas.
    Pai RK; Mackinnon AC; Joseph L; Noffsinger A; Hart J
    Am J Surg Pathol; 2010 Mar; 34(3):355-63. PubMed ID: 20118768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum.
    Wiland HO; Shadrach B; Allende D; Carver P; Goldblum JR; Liu X; Patil DT; Rybicki LA; Pai RK
    Am J Surg Pathol; 2014 Sep; 38(9):1290-7. PubMed ID: 25127095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved molecular classification of serrated lesions of the colon by immunohistochemical detection of BRAF V600E.
    Mesteri I; Bayer G; Meyer J; Capper D; Schoppmann SF; von Deimling A; Birner P
    Mod Pathol; 2014 Jan; 27(1):135-44. PubMed ID: 23887306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological features of CpG island methylator phenotype-positive colorectal cancer and its adverse prognosis in relation to KRAS/BRAF mutation.
    Lee S; Cho NY; Choi M; Yoo EJ; Kim JH; Kang GH
    Pathol Int; 2008 Feb; 58(2):104-13. PubMed ID: 18199160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and histologic considerations in the assessment of serrated polyps.
    Yang HM; Mitchell JM; Sepulveda JL; Sepulveda AR
    Arch Pathol Lab Med; 2015 Jun; 139(6):730-41. PubMed ID: 26030242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intermediate serrated polyp as an intermediate lesion of hyperplastic polyp and sessile serrated polyp/adenoma in terms of morphological and molecular features.
    Kwon HJ; Cho NY; Chang MS; Kim YS; Kang GH
    Hum Pathol; 2014 Aug; 45(8):1759-65. PubMed ID: 24935059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
    Velho S; Moutinho C; Cirnes L; Albuquerque C; Hamelin R; Schmitt F; Carneiro F; Oliveira C; Seruca R
    BMC Cancer; 2008 Sep; 8():255. PubMed ID: 18782444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high-level CpG Island methylator phenotype and mismatch repair-deficiency.
    Dawson H; Galván JA; Helbling M; Muller DE; Karamitopoulou E; Koelzer VH; Economou M; Hammer C; Lugli A; Zlobec I
    Int J Cancer; 2014 May; 134(10):2342-51. PubMed ID: 24166180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
    Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH
    APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic instability, CpG island methylator phenotype, and proliferative activity are distinct differences between diminutive and small tubular adenoma of the colorectum.
    Nando Y; Watari J; Ito C; Hara K; Yamasaki T; Okugawa T; Kondo T; Kono T; Tozawa K; Tomita T; Ohda Y; Oshima T; Fukui H; Matsubara N; Tomita N; Hirota S; Miwa H
    Hum Pathol; 2017 Feb; 60():37-45. PubMed ID: 27746269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels.
    Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH
    Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics.
    Rosty C; Buchanan DD; Walsh MD; Pearson SA; Pavluk E; Walters RJ; Clendenning M; Spring KJ; Jenkins MA; Win AK; Hopper JL; Sweet K; Frankel WL; Aronson M; Gallinger S; Goldblatt J; Woodall S; Arnold J; Walker NI; Jass JR; Parry S; Young JP
    Am J Surg Pathol; 2012 Jun; 36(6):876-82. PubMed ID: 22510757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 71.